Physician profile
Justin Smith
NPI 1326508649
$2,071.79
in general payments reported to CMS, 2019-2025
9 companies · $1,070 in 2025
The $1,070 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $152 · 2021: $208 · 2023: $225 · 2024: $417 · 2025: $1,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077 · Travel and Lodging: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.56 |
| Travel and Lodging | $635.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $835.33 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Abbott Laboratories | $443.40 | 2020-2024 | Jeti All In One Non-Sterile Kit, Jeti, Emboshield Nav6 |
| Penumbra, INC. | $208.12 | 2021 | |
| Boston Scientific Corporation | $171.41 | 2024-2025 | General - Vascular Intervention |
| Endologix LLC | $170.21 | 2025 | Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $118.37 | 2024 | Endurant Iis |
| Terumo Medical Corporation | $87.57 | 2023 | Metacross Otw, R2p Misago, Azur Cx Detachable |
| Ethicon US, LLC | $21.00 | 2025 | Vistaseal, Evarrest |
| Bard Peripheral Vascular, INC. | $16.38 | 2025 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.